GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI) » Definitions » Cyclically Adjusted PB Ratio

Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Cyclically Adjusted PB Ratio : 13.55 (As of Jun. 04, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Laboratorios Farmaceuticos Rovi Cyclically Adjusted PB Ratio?

As of today (2024-06-04), Laboratorios Farmaceuticos Rovi's current share price is €89.55. Laboratorios Farmaceuticos Rovi's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €6.61. Laboratorios Farmaceuticos Rovi's Cyclically Adjusted PB Ratio for today is 13.55.

The historical rank and industry rank for Laboratorios Farmaceuticos Rovi's Cyclically Adjusted PB Ratio or its related term are showing as below:

XMAD:ROVI' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 5.54   Med: 8.25   Max: 16.89
Current: 13.43

During the past years, Laboratorios Farmaceuticos Rovi's highest Cyclically Adjusted PB Ratio was 16.89. The lowest was 5.54. And the median was 8.25.

XMAD:ROVI's Cyclically Adjusted PB Ratio is ranked worse than
94.36% of 656 companies
in the Biotechnology industry
Industry Median: 1.745 vs XMAD:ROVI: 13.43

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Laboratorios Farmaceuticos Rovi's adjusted book value per share data for the three months ended in Mar. 2024 was €10.127. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €6.61 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Laboratorios Farmaceuticos Rovi Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Laboratorios Farmaceuticos Rovi's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Laboratorios Farmaceuticos Rovi Cyclically Adjusted PB Ratio Chart

Laboratorios Farmaceuticos Rovi Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.87 9.82 15.82 6.57 9.45

Laboratorios Farmaceuticos Rovi Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.70 7.09 8.28 9.45 12.24

Competitive Comparison of Laboratorios Farmaceuticos Rovi's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Laboratorios Farmaceuticos Rovi's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Laboratorios Farmaceuticos Rovi's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Laboratorios Farmaceuticos Rovi's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Laboratorios Farmaceuticos Rovi's Cyclically Adjusted PB Ratio falls into.



Laboratorios Farmaceuticos Rovi Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Laboratorios Farmaceuticos Rovi's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=89.55/6.61
=13.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Laboratorios Farmaceuticos Rovi's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Laboratorios Farmaceuticos Rovi's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=10.127/122.7621*122.7621
=10.127

Current CPI (Mar. 2024) = 122.7621.

Laboratorios Farmaceuticos Rovi Quarterly Data

Book Value per Share CPI Adj_Book
201406 3.030 101.081 3.680
201409 3.097 100.441 3.785
201412 3.189 100.251 3.905
201503 3.323 99.474 4.101
201506 3.225 101.138 3.915
201509 3.289 99.559 4.056
201512 3.341 100.268 4.091
201603 3.527 98.638 4.390
201606 3.560 100.333 4.356
201609 3.631 99.737 4.469
201612 3.722 101.842 4.487
201703 3.856 100.896 4.692
201706 3.855 101.848 4.647
201709 3.882 101.524 4.694
201712 3.887 102.975 4.634
201803 4.027 102.122 4.841
201806 3.916 104.165 4.615
201809 4.079 103.818 4.823
201812 5.191 104.193 6.116
201903 5.317 103.488 6.307
201906 5.404 104.612 6.342
201909 5.666 103.905 6.694
201912 5.821 105.015 6.805
202003 6.071 103.469 7.203
202006 6.359 104.254 7.488
202009 6.670 103.521 7.910
202012 6.746 104.456 7.928
202103 7.173 104.857 8.398
202106 7.290 107.102 8.356
202109 8.182 107.669 9.329
202112 8.592 111.298 9.477
202203 7.894 115.153 8.416
202206 7.476 118.044 7.775
202209 8.611 117.221 9.018
202212 9.929 117.650 10.360
202303 10.832 118.948 11.179
202306 9.680 120.278 9.880
202309 10.404 121.343 10.526
202312 10.409 121.300 10.534
202403 10.127 122.762 10.127

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Laboratorios Farmaceuticos Rovi  (XMAD:ROVI) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Laboratorios Farmaceuticos Rovi Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Laboratorios Farmaceuticos Rovi's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Laboratorios Farmaceuticos Rovi (XMAD:ROVI) Business Description

Traded in Other Exchanges
Address
Julian Camarillo, 35, Madrid, ESP, 28037
Laboratorios Farmaceuticos Rovi SA is a biotechnology company engaged in the research, development, manufacturing, and marketing of small molecule and specialty biologic drugs. The company has a diversified portfolio of products that it markets in Spain through its specialized sales force of specialist physicians, hospitals and pharmacies. Laboratorios' research and development pipeline is focused on the expansion of applications, indications, and alternative mechanisms of action for heparin-derived products. The company aims to obtain new pharmaceutical products that enable the regular administration of formulations that are administered daily in chronic and prolonged treatments. Its two segments are Manufacturing and Marketing.